859 reports of this reaction
3.7% of all LIOTHYRONINE SODIUM reports
#2 most reported adverse reaction
HEADACHE is the #2 most commonly reported adverse reaction for LIOTHYRONINE SODIUM, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 859 FDA adverse event reports linking LIOTHYRONINE SODIUM to HEADACHE. This represents approximately 3.7% of all 23,445 adverse event reports for this drug.
Patients taking LIOTHYRONINE SODIUM who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is moderately reported among LIOTHYRONINE SODIUM users, representing a notable but not dominant share of adverse events.
In addition to headache, the following adverse reactions have been reported for LIOTHYRONINE SODIUM:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 859 FDA reports for LIOTHYRONINE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 3.7% of all adverse event reports for LIOTHYRONINE SODIUM, making it one of the most commonly reported side effect.
If you experience headache while taking LIOTHYRONINE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.